Given the importance of TRPA1 and TRPV1 nociceptive sensory neurons in colitis-mediated nociception [1,10,11,12,13], the targeted inhibition of these nociceptors can be a promising therapeutic strategy for alleviation of IBD-associated pain. Here, TRPA1 is linked to inflammatory bowel disease.